Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Suppr

超能文献

作者信息

Pyörälä K, De Backer G, Graham I, Poole-Wilson P, Wood D

机构信息

Department of Medicine, University of Kuopio, Finland.

出版信息

Atherosclerosis. 1994 Oct;110(2):121-61. doi: 10.1016/0021-9150(94)90200-3.

DOI:10.1016/0021-9150(94)90200-3

PMID:7848365

Abstract

摘要

相似文献

Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Atherosclerosis. 1994 Oct;110(2):121-61. doi: 10.1016/0021-9150(94)90200-3.

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Eur Heart J. 1994 Oct;15(10):1300-31. doi: 10.1093/oxfordjournals.eurheartj.a060388.

[Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].

Arch Mal Coeur Vaiss. 1995 Oct;88(10 Suppl):1493-542.

[Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].

Rev Esp Cardiol. 1995 Dec;48(12):773-80.

[Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].

G Ital Cardiol. 1996 Feb;26(2):127-68.

[Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].

Cardiologia. 1996 Feb;41(2):149-82.

[Risk factor treatment and control in relation to coronary disease risk in the Spanish population of the DARIOS Study].

Rev Esp Cardiol. 2011 Sep;64(9):766-73. doi: 10.1016/j.recesp.2011.04.019. Epub 2011 Jul 20.

EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.

Eur Heart J. 1997 Oct;18(10):1569-82. doi: 10.1093/oxfordjournals.eurheartj.a015136.

[Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, The European Atherosclerosis Society and the European Hypertension Society. A short overview for general practitioners].

Lijec Vjesn. 1996 Oct;118(10):220-6.

Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

J Hypertens. 1998 Oct;16(10):1407-14. doi: 10.1097/00004872-199816100-00003.

引用本文的文献

Link between Yoga and Heart Rate Variability: Can Yoga Enhance the Cardiac Resonance.

Int J Yoga. 2024 May-Aug;17(2):67-75. doi: 10.4103/ijoy.ijoy_50_24. Epub 2024 Sep 13.

The estimated 10-year risk of first-onset cardiovascular disease in Swedish-born and non-Swedish-born primary healthcare patients.

BMC Prim Care. 2024 Jun 4;25(1):198. doi: 10.1186/s12875-024-02446-w.

25 years of lipid-lowering therapy: secular trends in therapy of coronary patients.

Wien Klin Wochenschr. 2025 May;137(9-10):297-306. doi: 10.1007/s00508-024-02365-x. Epub 2024 May 14.

Ethnicity based differences in statin use and hypercholesterolemia control among patients with premature coronary artery disease-results of I-PAD study.

Int J Cardiol Cardiovasc Risk Prev. 2023 Jan 14;16:200168. doi: 10.1016/j.ijcrp.2023.200168. eCollection 2023 Mar.

A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference group.

Br J Sports Med. 2020 Nov;54(21):1294-1299. doi: 10.1136/bjsports-2019-101749. Epub 2020 Jul 17.

Care management of patients with high cardiovascular risk in Hungary an international and Hungarian longitudinal comparison of target level achievement.

BMC Fam Pract. 2020 May 8;21(1):83. doi: 10.1186/s12875-020-01150-9.

Co-morbidity index in rheumatoid arthritis: time to think.

Clin Rheumatol. 2015 Dec;34(12):1995-2000. doi: 10.1007/s10067-015-3101-0. Epub 2015 Oct 26.

2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice.

Acta Pharmacol Sin. 2015 Apr;36(4):483-96. doi: 10.1038/aps.2014.149. Epub 2015 Mar 16.

EULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: an audit of the success of implementation in a rheumatology outpatient clinic.

Biomed Res Int. 2015;2015:515280. doi: 10.1155/2015/515280. Epub 2015 Mar 1.

A six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting(estudio del control de las hiperlipidemiasen atención primaria): the cheap study.

Curr Ther Res Clin Exp. 2003 Jun;64(6):338-54. doi: 10.1016/S0011-393X(03)00090-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验